Effects of supplementation with carnosine and other histidine-containing dipeptides on chronic disease risk factors and outcomes: protocol for a systematic review of randomised controlled trials

被引:23
|
作者
Menon, Kirthi [1 ]
Mousa, Aya [1 ]
de Courten, Barbara [1 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia
来源
BMJ OPEN | 2018年 / 8卷 / 03期
关键词
BETA-ALANINE SUPPLEMENTATION; EXERCISE PERFORMANCE; DIABETES-MELLITUS; PHYSICAL CAPACITY; CANCER CELLS; METAANALYSIS; MUSCLE; RATS; MICE; POLYMORPHISM;
D O I
10.1136/bmjopen-2017-020623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Ageing of populations globally, coupled with the obesity epidemic, has resulted in the rising prevalence of chronic diseases including diabetes, cardiovascular diseases, cancers and neurodegenerative disorders. Prevention of risk factors that contribute to these diseases is key in managing the global burden of chronic diseases. Recent studies suggest that carnosine, a dipeptide with anti-inflammatory, antioxidative and antiglycating properties may have a role in the prevention of chronic diseases; however, no previous reviews have examined the effects of carnosine and other histidine-containing peptides (HCDs) on chronic disease risk factors and outcomes. We aim to conduct a comprehensive systematic review to examine the effects of supplementation with carnosine and other HCDs on chronic disease risk factors and outcomes and to identify relevant knowledge gaps. Methods and analysis Electronic databases including Medline, Cumulative Index of Nursing and Allied Health, Embase and all Evidence-Based Medicine will be systematically searched to identify randomised controlled trials (RCTs) and systematic reviews of RCTs, comparing supplementation with carnosine and/or other HCDs versus placebo, usual care or other pharmacological or non pharmacological interventions. One reviewer will screen titles and abstracts for eligibility according to prespecified inclusion criteria, after which two independent reviewers will perform data extraction and quality appraisal. Meta analyses, metaregression and subgroup analyses will be conducted where appropriate. Ethics and dissemination Ethics approval is riot required as this review does not involve primary data collection. This review will generate level-one evidence regarding the effects of carnosine supplementation on chronic disease risk factors and outcomes and will be disseminated through peer-reviewed publications and at conference meetings to inform future research on the efficacy of carnosine supplementation for the prevention of chronic diseases.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Carnosine and histidine-containing dipeptides improve dyslipidemia: a systematic review and meta-analysis of randomized controlled trials
    Menon, Kirthi
    Marquina, Clara
    Hoj, Pernille
    Liew, Danny
    Mousa, Aya
    de Courten, Barbora
    NUTRITION REVIEWS, 2020, 78 (11) : 939 - 951
  • [2] Supplementation with Histidine-Containing Dipeptides Improves Cardiometabolic Risk Factors: A Meta-analysis of Randomized Controlled Trials
    Menon, Kirthi Aravind
    Mousa, Aya
    Marquina, Clara
    De Courten, Barbora
    DIABETES, 2019, 68
  • [3] Effects of carnosine and histidine-containing dipeptides on biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis
    Saadati, Saeede
    Kabthymer, Robel Hussen
    Aldini, Giancarlo
    Mousa, Aya
    Feehan, Jack
    de Courten, Barbora
    NUTRITION REVIEWS, 2023, 82 (12) : 1696 - 1709
  • [4] Carnosine/histidine-containing dipeptide supplementation improves depression and quality of life: systematic review and meta-analysis of randomized controlled trials
    Kabthymer, Robel Hussen
    Saadati, Saeede
    Lee, Mark
    Hariharan, Rohit
    Feehan, Jack
    Mousa, Aya
    de Courten, Barbora
    NUTRITION REVIEWS, 2024, 83 (02)
  • [6] Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials
    Menon, Kirthi
    Marquina, Clara
    Liew, Danny
    Mousa, Aya
    de Courten, Barbora
    OBESITY REVIEWS, 2020, 21 (03)
  • [7] Comments upon "Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials"
    Matthews, Joseph J.
    Sale, Craig
    OBESITY REVIEWS, 2020, 21 (07)
  • [8] Effects of inulin-type fructans supplementation on cardiovascular disease risk factors: a protocol for a systematic review and meta-analysis of randomised controlled trials
    Talukdar, Jhalok Ronjan
    Cooper, Matthew Adam
    Lyutvyn, Lyuba
    Zeraatkar, Dena
    Ali, Rahim
    Bierbrier, Rachel
    Janes, Sabrina
    Ha, Vanessa
    Darling, Pauline B.
    Sievenpiper, John L.
    Jenkins, David J. A.
    Banfield, Laura
    Mbuagbaw, Lawrence
    de Souza, Russell J.
    BMJ OPEN, 2022, 12 (07):
  • [9] Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials
    Clarke, Rachel E.
    Dordevic, Aimee L.
    Tan, Sih Min
    Ryan, Lisa
    Coughlan, Melinda T.
    NUTRIENTS, 2016, 8 (03)
  • [10] Factors associated with recruitment to randomised controlled trials in general practice: protocol for a systematic review
    Keith R. Moffat
    Paul Cannon
    Wen Shi
    Frank Sullivan
    Trials, 20